Get the Stockscreener App
9.21
5.86%
0.51
After Hours:
9.27
0.06
+0.65%
Organon Co stock is traded at $9.21, with a volume of 9.61M.
It is up +5.86% in the last 24 hours and up +45.04% over the past month.
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
See More
Previous Close:
$8.70
Open:
$8.72
24h Volume:
9.61M
Relative Volume:
1.72
Market Cap:
$2.40B
Revenue:
$6.22B
Net Income/Loss:
$187.00M
P/E Ratio:
12.85
EPS:
0.7166
Net Cash Flow:
$508.00M
1W Performance:
+57.17%
1M Performance:
+45.04%
6M Performance:
-3.56%
1Y Performance:
-16.65%
1-Day Range:
$8.335
$9.35
1-Week Range:
$5.82
$9.35
52-Week Range:
$5.69
$13.24
Organon Co Stock (OGN) Company Profile
Name
Organon Co
Sector
Industry
Phone
551-430-6000
Address
30 HUDSON STREET, JERSEY CITY
Compare OGN vs LLY, JNJ, ABBV, AZN, MRK
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
9.21 | 2.26B | 6.22B | 187.00M | 508.00M | 0.7166 |
LLY
Lilly Eli Co
|
905.03 | 824.12B | 65.18B | 20.64B | 5.96B | 22.59 |
JNJ
Johnson Johnson
|
238.67 | 578.31B | 94.19B | 26.80B | 19.70B | 11.05 |
ABBV
Abbvie Inc
|
208.42 | 371.90B | 61.16B | 4.19B | 17.82B | 2.3614 |
AZN
Astrazeneca Plc
|
201.21 | 316.96B | 58.80B | 10.24B | 8.98B | 3.2788 |
MRK
Merck Co Inc
|
117.90 | 296.29B | 64.93B | 18.26B | 12.36B | 7.2751 |
Organon Co Stock (OGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Underweight |
| Oct-27-25 | Downgrade | Piper Sandler | Overweight → Underweight |
| May-02-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Sep-06-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-03-23 | Downgrade | Goldman | Buy → Neutral |
| Sep-21-23 | Initiated | Barclays | Overweight |
| Mar-16-23 | Initiated | Raymond James | Outperform |
| Oct-14-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-06-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-27-22 | Initiated | Goldman | Buy |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-07-21 | Initiated | Piper Sandler | Neutral |
| Sep-01-21 | Initiated | BofA Securities | Buy |
| Jul-22-21 | Initiated | Citigroup | Buy |
| Jun-15-21 | Initiated | JP Morgan | Neutral |
| Jun-11-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-10-21 | Initiated | Evercore ISI | Outperform |
View All
Organon Co Stock (OGN) Latest News
AAD recommends Organon’s VTAMA cream for pediatric atopic dermatitis - Investing.com
Only steroid-free cream AAD backs for all child eczema severities - Stock Titan
Organon & Co. Shares Drop 6.4% as Analysts Forecast Weak Growth - National Today
Organon (OGN) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Organon rises as Sun Pharma said to near $12B buyout deal - MSN
3 Reasons to Avoid OGN and 1 Stock to Buy Instead - Yahoo Finance
Unusually active option classes on open April 13th - TipRanks
Organon Takeover At $15? Probably Not, Here's Why (NYSE:OGN) - Seeking Alpha
Organon Stock Skyrockets 28% Following Reports of $12 Billion Buyout Offer From Sun Pharma - TIKR.com
Sun Pharma’s Reported US$12b Bid Recasts Organon’s Risk Reward Profile - Sahm
American pharmaceutical MSD receiving billions in tax benefits in the Netherlands - NL Times
Sun Pharma Officially Denies $12 Billion Organon Acquisition Speculation - scanx.trade
EBIT per share of Organon & Co. – SWB:7XP - TradingView — Track All Markets
Is Organon (OGN) Now An Opportunity After Its Recent Share Price Surge? - Yahoo Finance
Buy or Sell Organon Stock in 2026? Takeover Buzz Lifts Shares 28% as Analysts Stay Cautious - International Business Times Australia
Institutional Money Floods Organon as Analysts Warn and Charts Conflicted - Bitget
Organon (OGN) Climbs 39% on $12-Billion Merger Buzz - Insider Monkey
Key deals this week: Organon, UMG, Whitestone REIT, Gilead and more - Seeking Alpha
Avoiding Lag: Real-Time Signals in (OGN) Movement - Stock Traders Daily
Organon Shares Soar as Sun Pharmaceutical Eyes $12B Deal - timothysykes.com
Morning Movers: Organon jumps after report of Sun Pharmaceutical bid - Yahoo Finance
Sun Pharma Nears Final Offer For Organon In Largest Overseas Bet - Sahm
What does Sun Pharma gain from its $12-billion Organon bid? - Business Today
OGN Analyst Rating Maintained at Outperform by BNP Paribas - Meyka
Sun Pharma Submits $12B Bid for Organon, Shares Surge - Intellectia AI
This Women’s Health Company Is Drawing Takeover Interest. The Stock Is Soaring. - Barron's
BNP Paribas Maintains Organon & Co(OGN.US) With Buy Rating, Cuts Target Price to $15 - Moomoo
Morgan Stanley Maintains Organon & Co(OGN.US) With Hold Rating, Maintains Target Price $9 - Moomoo
Organon (OGN) Stock Rockets 41% as Sun Pharma Submits $12B Buyout Proposal - MEXC
Organon (OGN) Stock Surges 41% on $12 Billion Sun Pharma Takeover Bid - MEXC
Organon Shares Surge on $12 Billion Takeover Bid from Sun Pharma - AD HOC NEWS
Sun Pharma readies $12B offer for Organon: report - FirstWord Pharma
Sun Pharma Plans USD 12 Billion Organon Acquisition, Prepares Binding Bid: Report - Medical Dialogues
Organon Rumors Persist Despite Sun’s Fresh Denial - Citeline News & Insights
Potential Acquisition Rumors Keep Organon (OGN) on the Rise - GuruFocus
Organon, CoreWeave, WhiteFiber And Other Big Stocks Moving Higher On Friday - Benzinga
Sun Pharma's $12B Organon Bid Rumors Spark Stock Drop, Debt Fears - Whalesbook
Organon & Co. (OGN) is attracting investor attention: Here is what you should know - MSN
M&A News: Organon Stock (OGN) Surges 26% on Reported Sun Pharma Bid - TipRanks
US Stocks Mixed; Dow Falls Over 100 Points - Benzinga
Organon & Co. (OGN) is Drawing Interest from Investors: Key Information You Need to Know - Bitget
Sun Pharmaceutical to proceed with $12B bid for Organon, Economic Times says - TipRanks
Sun says Organon takeover report ‘speculative in nature’ - TipRanks
Organon deal interest report bodes well for sector valuation, says Evercore ISI - TipRanks
Organon Stock Explodes 17% on Takeover Speculation as Women's Health Drugmaker Draws Buyer Interest - International Business Times Australia
This Women’s Healthcare Stock Is Up 15% on Reports of a Takeover In the Works - Yahoo Finance
Organon’s Phase 3 Data Boosts Vtama Cream’s Market Potential - timothysykes.com
These Stocks Are Today's Movers: Lumentum, Coherent, Sandisk, Palo Alto, Organon, Palantir, and More -- Barrons.com - Moomoo
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
OGN stock surges 20% pre-market, on track to break 200-DMA – why this buyout report has caught investor attention - MSN
OGN Stock Surges 20% Pre-Market, On Track To Break 200-DMA – Why This Buyout Report Has Caught Investor Attention - Stocktwits
Organon Co Stock (OGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.30%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):